Clinical Trial Update: Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for apomorphine nasal powder in Parkinson's disease focusing on 'off' periods, spanning Phase 2 and Phase 3 and completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• apomorphine nasal powder (apomorphine)

Snippet

Sponsor: Britannia Pharmaceuticals Ltd. | Conditions: Parkinson's Disease | Phase 2, Phase 3 | Status: COMPLETED